Abacus Bioscience Inc.

UEI
DXS6HM6CLDF5
CAGE
8JP28
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of novel CD180-based cancer immunotherapeutics - program director/principal investigator (last, first… R41CA257531 National Cancer Institute (NIH) $796,080

Grant subawards

Prime recipient Prime award Amount Awarded
Oregon Health & Science University "Targeting CD180 to induce anti-KSHV response in nonhuman primates " U01CA295049 $139,454

Quick answers

Is Abacus Bioscience Inc. registered in SAM.gov?

Abacus Bioscience Inc.'s SAM.gov registration expired on June 9, 2023.

What is Abacus Bioscience Inc.'s most recent federal award?

Abacus Bioscience Inc.'s most recent federal grant award is Development of novel CD180-based cancer immunotherapeutics - program director/principal investigator (last, first… (R41CA257531), from National Cancer Institute (NIH), on June 1, 2022.

On GovTribe

See Abacus Bioscience Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login